Alexion Pharmaceuticals (Alexion Pharmaceuticals) EV-to-EBIT : 64.47 (As of Apr. 26, 2024)

Alexion Pharmaceuticals EV-to-EBIT Chart

Alexion Pharmaceuticals Annual Data
	Trend	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20
EV-to-EBIT		Get a 7-Day Free Trial					43.68	43.86	69.64	10.79	50.57

Alexion Pharmaceuticals Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21
EV-to-EBIT	Get a 7-Day Free Trial															8.37	45.15	37.27	50.57	54.04

Competitive Comparison of Alexion Pharmaceuticals's EV-to-EBIT

For the Biotechnology subindustry, Alexion Pharmaceuticals's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alexion Pharmaceuticals's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alexion Pharmaceuticals's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Alexion Pharmaceuticals's EV-to-EBIT falls into.

Alexion Pharmaceuticals EV-to-EBIT Calculation

Alexion Pharmaceuticals's EV-to-EBIT for today is calculated as:

Alexion Pharmaceuticals's current Enterprise Value is $39,584 Mil.
Alexion Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Mar. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $614 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alexion Pharmaceuticals  (NAS:ALXN) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Alexion Pharmaceuticals's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2021 is calculated as:

Alexion Pharmaceuticals's Enterprise Value for the quarter that ended in Mar. 2021 was $33,026 Mil.
Alexion Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Mar. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $614 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alexion Pharmaceuticals EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Alexion Pharmaceuticals's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Alexion Pharmaceuticals (Alexion Pharmaceuticals) Business Description